TNF and rheumatoid arthritis: However, a comparable study in 18 Brazilian RA patients also found that periodontal parameters before and after starting anti-TNF therapy (infliximab, etanercept and adalimumab) remained stable throughout the study period of 6 months, while an improvement in the most analyzed RA parameters was observed [24].